Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Axial Chiral Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110002980A reveals Pd-catalyzed asymmetric naphthylation for high-ee chiral aldehydes. Offers supply chain stability and cost reduction in chiral catalyst manufacturing.
Patent CN116947580A enables high-yield axially chiral compound production. Offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.
Novel Rh-catalyzed C-H activation method for high-purity axial chiral intermediates with superior enantioselectivity and scalable process efficiency.
Novel axial chiral bisindole catalyst synthesis offers high enantioselectivity and mild conditions for cost reduction in pharmaceutical intermediate manufacturing and reliable supply chain.
Patent CN111848322B details a mild resolution method for axially chiral oxindole styrenes using chiral phosphoric acid, offering high enantioselectivity for pharma applications.
Patent CN117720537B reveals a novel indole-furan catalyst enabling high-purity asymmetric synthesis with significant cost reduction in fine chemical manufacturing and supply chain reliability.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN114920775B details novel axial chiral bisindole catalyst synthesis offering high stereoselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel synthesis method offers high enantioselectivity and cost reduction for asymmetric MBH and cyclization reactions in pharmaceutical manufacturing.
Novel synthesis method offers high enantioselectivity and mild conditions for asymmetric reactions, ensuring reliable supply chain and cost efficiency.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel axial chiral indole-furan catalyst patent CN117720537B enables mild asymmetric synthesis. Offers high enantioselectivity and cost-effective manufacturing for reliable pharma intermediate supply chains.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN114920775B introduces a novel axial chiral bisindole catalyst offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.